Starting Oct. 1, a Louisiana law will classify drugs used for abortion — mifepristone and misoprostol — as controlled substances, requiring hospitals to store them in locked cabinets, The Washington Post reported Sept. 17.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
